The CDC’s Advisory Committee on Immunization Practices gathered on December 4, 2025, in Atlanta. They focused on potential changes to the hepatitis B vaccine for newborns. Advisers also reviewed the broader childhood immunization schedule during the two-day session.
Moreover the panel led by Chair Dr. Kirk Milhoan and facilitated by Dr. Robert Malone, included new members appointed by HHS Secretary Robert F. Kennedy Jr. This shift followed the dismissal of previous advisers.
The Postponement Decision
Advisers planned to vote on abandoning the universal hepatitis B birth dose. However they postponed the vote to Friday after a heated debate. The motion to delay passed six to three, allowing time to refine wording and review data.
In addition, members pointed to evidence gaps in the presentations. Those presenting included critics like Aaron Siri and Mark Blaxill, who questioned vaccine safety.
Discussions on Immunization Schedule
The committee reviewed vaccine ingredients and timing. They listened to presentations regarding hepatitis B trends and risks for infants.
Furthermore experts warned that delaying the birth dose could increase chronic infections. Public health groups stressed the vaccine’s role in reducing cases by 99% since 1990.
Expert and Public Reactions
Critics cited data quality. Physicians mentioned neonatal risks from infected mothers. However supporters of the delay spoke about parental choice and safety reviews.
Future Implications
The panel will vote on Friday. The changes could affect insurance coverage and state mandates. In conclusion, this delay reflects the continuing vaccine controversies. It has to be comprehensive in making decisions about the health of children.
